Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia
Martina Pasino(Ospedale Policlinico San Martino), Paola Menichini(Ospedale Policlinico San Martino)
Cited by 2
Related Papers
Mutant p53K120R expression enables a partial capacity to modulate metabolism
|Frontiers in Genetics|2022|7